Bertil Glader

Stanford Medicine Professor of Pediatric Hematology/Oncology and Professor, by courtesy, of Pathology

Clinical Focus

Pediatric Hematology-Oncology

Academic Appointments

Professor, Pediatrics - Hematology & Oncology
Professor (By courtesy), Pathology
Member, Maternal & Child Health Research Institute (MCHRI)

Administrative Appointments

Instructor in Pediatrics, Harvard Medical School (1973 - 1974)
Assistant Professor of Pediatrics, Harvard Medical School (1974 - 1977)
Associate Professor of Pediatrics, Stanford University (1977 - 1987)
Professor of Pediatrics, Stanford University (1987 - Present)

Professional Education

Internship: Stanford Health Care at Lucile Packard Children's Hospital (1969) CA
Fellowship: Boston Childrens Hospital Pediatric Hematology and Oncology Fellowship (1974) MA
Residency: Children's Hospital Boston Medical Center Pediatric Residency (1973) MA
Medical Education: Northwestern University Feinberg School of Medicine (1968) IL
Board Certification: American Board of Pediatrics, Pediatrics (1982)
Board Certification: American Board of Pediatrics, Pediatric Hematology-Oncology (1982)
Board Certification: American Board of Pathology, Hematology (1983)
BA, Northwestern University, Philosophy (1961)
PhD, University of Illinois, Physiology (1967)
MD, Northwestern University, Medicine (1968)

Contact

Academic bglader@stanford.edu Tel: (650) 723-5152Tel: (650) 723-5535 Fax: (650) 723-5231

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Bass Cancer Center for Childhood Cancer and Blood Diseases 725 Welch Rd MC 5913 Palo Alto CA 94304 Tel: (650) 497-8953 Fax: (650) 725-3219

Additional Clinical Info

Stanford Medicine Children's Health

Current Research and Scholarly Interests

Hematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary red blood cell disorders-clinical trials.

Clinical Trials

Pyruvate Kinase Deficiency Natural History Study Not Recruiting
More
The purpose of this study is to describe the range and incidence of symptoms, treatments, and complications related to pyruvate kinase deficiency (PKD). Eligible patients are those of all ages with known PKD or with a hemolytic anemia and a family member with PKD. The study will collect retrospective medical history, routine clinical care data, and quality of life measures at baseline and annually for patients with PKD.

Stanford is currently not accepting patients for this trial. For more information, please contact Heather Hilmoe, CRA, 650-725-1662.
Lead Sponsor
Stanford Investigators
- Bertil Glader
View full details
A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency Recruiting
More
Study AG348-C-003 is a multicenter study designed to evaluate the safety and efficacy of different dose levels of AG-348 (mitapivat) in participants with PK deficiency.
Lead Sponsor
Stanford Investigators
- Anupama Narla
- Bertil Glader
View full details

2023-24 Courses

Independent Studies
- Directed Reading in Pediatrics
  PEDS 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience
  PEDS 280 (Aut, Win, Spr, Sum)
- Graduate Research
  PEDS 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  PEDS 370 (Aut, Win, Spr, Sum)
- Undergraduate Directed Reading/Research
  PEDS 199 (Aut, Win, Spr, Sum)

All Publications

Profiles With Related Publications

close
Ranjana Advani

Saul A. Rosenberg, MD, Professor of Lymphoma
Clinical Focus
Cancer > Lymphoma, Burkitt's Lymphoma, Hodgkin's Disease, Investigational Therapeutics, Lymphoma , Mycosis Fungoides, Non-Hodgkin's Lymphoma, Oncology (Cancer), Plasmacytoma, Waldenstrom's Macroglobulinemia , Medical Oncology
Research Interests
Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.

The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.

664 Total Publications
close
Ash A. Alizadeh, MD/PhD

Moghadam Family Professor
Clinical Focus
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
Research Interests
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

401 Total Publications
close
Michael Amylon

Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Research Interests
Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.

105 Total Publications
close
Glaivy Batsuli, MD

Assistant Professor of Pediatrics (Hematology/Oncology)
Clinical Focus
Pediatric Hematology-Oncology

42 Total Publications
close
William Berquist

Professor of Pediatrics (Gastroenterology), Emeritus
Clinical Focus
Pediatric Gastroenterology, Ped Gastroenterology
Research Interests
Gastroenterology, gastointestinal motility, clinical management of pediatric liver transplant recipients.

107 Total Publications
close
Alice Bertaina MD, PhD

Lorry I. Lokey Professor
Clinical Focus
Pediatric Stem Cell Transplantation, Graft engineering, Pediatric Hematology-Oncology

194 Total Publications
close
Gary Dahl

Professor of Pediatrics (Hematology/Oncology), Emeritus
Research Interests
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.

171 Total Publications
close
Edgar Engleman

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Research Interests
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

286 Total Publications
close
Uta Francke

Professor of Genetics and of Pediatrics, Emerita
Clinical Focus
Neurogenetics, Clinical Genetics, Marfan syndrome, Williams syndrome, Heritable connective tissue disorders
Research Interests
Functional consequences and pathogenetic mechanisms of mutations and microdeletions in human neurogenetic syndromes and mouse models. Integration of genomic information into medical care.

564 Total Publications
close
Lawrence Tim Goodnough

Professor of Pathology and of Medicine (Hematology), Emeritus
Research Interests
Improving blood utilization
Promoting alternatives to blood transfusion
Quality improvements

418 Total Publications
close
Peter Greenberg

Professor of Medicine (Hematology), Emeritus
Clinical Focus
Cancer > Hematology, Hematology, Myelodysplastic Syndromes

337 Total Publications
close
Michael Jeng

Professor of Pediatrics (Hematology/Oncology)
Clinical Focus
Hematology, Pediatric, Vascular anomalies, Histiocytic disorders, Langerhans cell histiocytosis, Hemophagocytic Lymphohistiocytosis, Pediatric Hematology-Oncology
Research Interests
Research interests focus on: 1) histiocytic disorders, such as Langerhans cell histiocytosis (LCH) and hemophagocytic lymphohistiocytosis (HLH), and 2) vascular anomalies and malformations.

104 Total Publications